UNSPSC 51286502: Mupirocin calcium

This classification denotes a topical anti-infective agent with the molecular structure 2C26H43O9.CA.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RG38I2P540 chemically known as (.alpha.e,2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-.beta.-methyl-2h-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate, but more commonly known as mupirocin calcium, which bears US NIH Compound Identifier 5282317.

European Medicines Agency schedules Mupirocin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14612MIG.

UNSPSC 51286502 Mupirocin calcium is a Commodity code for a specific pharmaceutical active ingredient, yet the recent state and local opportunities posted under this code do not reflect purchases of mupirocin calcium itself. Instead, the opportunities show procurement of unrelated pharmaceutical products and medical supplies—doxycycline hyclate, ciprofloxacin hydrochloride, naloxone, and drug deactivation systems. This mismatch suggests either misclassification by the issuing bodies or that the code is not currently being used to solicit mupirocin calcium at the state and local level. The opportunities that do appear under this code involve health departments and county governments seeking bulk pharmaceutical supplies and emergency medical equipment through competitive bidding processes, typically structured as piggyback awards from existing state or regional purchasing consortia and fixed-term contracts with renewal options.

Activity under UNSPSC 51286502 is minimal and geographically scattered. The Illinois Department of Public Health conducted a piggyback procurement through the MMCAP Infuse consortium (Bid Number 26-482DPH-PREPD-B-53392, posted August 28, 2026, due September 11, 2026) that awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC for antibiotic tablets. Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) seeking naloxone and drug deactivation systems for quarterly delivery to its Community Health Building in Sanford. Neither opportunity directly solicits mupirocin calcium, and the code shows no clear alignment with current state and local procurement activity.